Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Apr;85(4):426-33.
doi: 10.1111/j.1349-7006.1994.tb02376.x.

Active efflux system for cisplatin in cisplatin-resistant human KB cells

R Fujii  1 , M Mutoh, K Niwa, K Yamada, T Aikou, M Nakagawa, M Kuwano, S Akiyama
Affiliations

Active efflux system for cisplatin in cisplatin-resistant human KB cells

R Fujii et al. Jpn J Cancer Res. 1994 Apr.

Abstract

Mutants, KCP-4 and PC-5, resistant to an anticancer agent, cisplatin, were selected in multiple steps from human epidermoid KB carcinoma cells and human prostate PC-3 carcinoma cells, respectively. KCP-4 and PC-5 were 63 and 10 fold more resistant to cisplatin than the parental cells, respectively. KCP-4 cells exhibited increased resistance to cisplatin analogues and were also slightly cross-resistant to melphalan, cyclophosphamide, mitomycin C and methotrexate. KCP-4 cells were not cross-resistant to doxorubicin, daunorubicin, vincristine or CdSO4. The accumulations of cisplatin in KCP-4 cells and PC-5 in medium containing 50 microM cisplatin were approximately 20% of those in the parental cells. Revertant analysis suggested that a defect in cisplatin accumulation may be related to cisplatin resistance in PC-5 cells. The uncoupling agent of oxidative phosphorylation, 2,4-dinitrophenol, increased the accumulation of cisplatin in KCP-4 and cisplatin-resistant human prostate carcinoma PC-5 cells to nearly the same level as in their parental KB-3-1 and human prostate carcinoma PC-3 cells without 2,4-dinitrophenol, but did not increase accumulation in KB-3-1 and PC-3 cells. Addition of glucose in the medium inhibited the enhancement of cisplatin accumulation in KCP-4 cells by 2,4-dinitrophenol. Enhanced active efflux of cisplatin from KCP-4 cells was observed. A cell-cell hybridization test showed that the cisplatin resistance and the accumulation defect behaved as codominant traits. These data suggest that an active efflux system for cisplatin exists in cisplatin-resistant KCP-4 cells.

PubMed Disclaimer

References

    1. ) Loehrer , P. J. and Einhorn , L. H.Cisplatin . Ann. Intern. Med. , 100 , 704 – 713 ( 1984. ). - PubMed
    1. ) Hamilton , J. C. , Lai , G.‐M. , Rothenberg , M. L. , Fojo , A. T. , Young , R. C. and Ozols , R. F.Mechanisms of resistance to cisplatin and alkylating agents . In “ Drug Resistance in Cancer Therapy ,” ed. Ozols R. F. , pp. 151 – 169 ( 1989. ). Kluwer Academic Publishers; , Norwell , MA . - PubMed
    1. ) Saburi , Y. , Nakagawa , M. , Ono , M. , Sakai , M. , Muramatsu , M. , Kohno , K. and Kuwano , M.Increased expression of glutathione S‐transferase gene in cis‐diamminedichloroplatinum(II)‐resistant variants of a Chinese hamster . Cancer Res. , 49 , 7020 – 7025 ( 1989. ). - PubMed
    1. ) Nakagawa , Y. , Yokota , J. , Wada , M. , Sasaki , Y. , Fujiwara , Y. , Sakai , M. , Muramatsu , M. , Terasaki , T. , Tsunokawa , Y. , Terada , M. , and Saijo , N.Levels of glutathione S transferase π mRNA in human lung cancer cell lines correlate with the resistance to cisplatin and carboplatin . Jpn. J. Cancer Res. , 79 , 301 – 304 ( 1988. ). - PMC - PubMed
    1. ) Ward , W. R.Differential uptake of cis‐diamminedichloroplatinum(II) by sensitive and resistant murine LI210 leukemia cells . Cancer Res. , 47 , 6549 – 6555 ( 1987. ). - PubMed

Publication types

LinkOut - more resources